Related Experiment Video
Updated: Mar 27, 2026

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
Published on: December 16, 2022
[Triumphal march of cancer therapy goes on]
Abstract:
Therapeutic results for cancer have gradually improved. The relative five-year survival rate of those affected with the disease already exceeds 65% in Finland. New cancer therapies play an indisputable role in the improvement of the prognosis. Besides therapy and its availability, many other causes may also have a considerable effect on the survival of affected persons, making comparison of regional survival rates unreliable as a measure of cancer treatment. The review deals with factors affecting the survival of persons having cancer and includes descriptions of some of the most recent cancer treatments and a discussion about the challenges of developing cancer therapies.
More Related Videos
Related Concept Videos
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
Treatment Resistent Cancers
Tumor Immunotherapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

